Former Netchemia CEO, KC venture capitalist launch new fund for Midwest software firms
February 1, 2018 | Bobby Burch
Keith Harrington isn’t looking for hockey-stick growth companies.
With the new fund he’s co-leading — Novel Growth Partners — Harrington wants to invest in small, steadily-growing tech companies in the Midwest. But instead of a traditional venture capital model, Novel is employing a revenue-based finance model that should appeal to more entrepreneurs, Harrington said.
“We believe that the current financing ecosystem excludes the majority of companies seeking financing. We know that only a small percentage of companies get venture capital and most young companies are too small for private equity and can’t get meaningful bank financing,” said Harrington, a former managing director at Kansas Bioscience Authority and recent Kauffman Fellow graduate. “We also recognize that there is a very large set of early-stage companies with revenue and growth that can benefit from the unique combination of capital and operational expertise we deploy.”
Harrington partnered with former Netchemia CEO Carlos Antequera to launch the fund. Antequera’s former firm sold to Vista Equity Partners in 2015.
With decades of business experience, the duo was inspired by challenges they recognized in firms’ ability to attract the appropriate type of funding — particularly in markets with limited access early-stage capital.
Here’s how Novel’s royalty-like model works:
Instead of taking portfolio company’s equity — thus requiring it to sell to generate a large return on the investment — Novel’s investment gets paid back at a set monthly percentage of the company’s revenue. The percentage is usually between 4 and 8 percent of the portfolio firm’s monthly revenue up to a predetermined return cap of up to five years. Novel provides developing software companies $100,000 to $500,000 in growth capital.
As a result, the entrepreneur is able to preserve ownership while growing the value of the company.
Novel plans to further add value to its portfolio firms by offering a boot camp focused on identifying and executing specific projects to accelerate revenue growth, Antequera said. During the boot camp, Novel props up new systems, automates processes and helps identify talent that will accelerate sales, Antequera said.
“We’re on a mission to provide capital to companies that have some revenue, customers and are focused on improving their business fundamentals, but in addition to capital, need improved sales systems, processes and talent to grow,” said Antequera. “Because venture requires rapid scaling, it is not the right type of capital for many companies. Equity venture investors cannot fund slow-growth opportunities. That’s where we come in, our model allows us to provide capital to companies with steady growth.”
Featured Business
2018 Startups to Watch
stats here
Related Posts on Startland News
LaunchKC, Techweek to welcome 10 tech firms to KC in style
In roughly four months, Kansas City will welcome a crop of tech startups bolstered by thousands of dollars in funding and a rockstar arrival. Kansas City’s LaunchKC competition — which aims to attract 10 tech firms to relocate to KC with $50,000 grants — has partnered with national tech conference Techweek to offer the winners…
New platform GUILDit offers art entrepreneurs visibility
A new program called GUILDit to promote and support art entrepreneurship is coming to Kansas City. The program is a bi-monthly gathering where art entrepreneurs take the stage to give six-minute presentations followed by questions and answers in the hopes of crafting a stronger Kansas City art economy, and to further connections between local artists.…
In time for Mother’s Day: Ovatemp wants to boost women’s fertility
The arrival of Ana Mayer’s baby girl isn’t the only thing she’ll be thinking about this Mother’s Day. Mayer — who’s among the newest founders in the Techstars-led Sprint Mobile Health Accelerator in Kansas City — will also be mulling how to further develop Ovatemp, the Boston-based ovulation tech company she leads. Ovatemp offers women…